癌 の ヒストロジック 変異: 臨床 翻訳 の 道
Ioannis Vathiotis1, Avisek Banerjee2,3, Utsav Sen2
1Third Department of Internal Medicine, Sotiria Thoracic Diseases Hospital of Athens, National and Kapodistrian University of Athens, Athens, Greece.
Cancer discovery
|September 4, 2025
まとめ
癌細胞は 治療に耐えるよう タイプを変えます この過程は 系統の可塑性と呼ばれます このレビューでは バイオプシーと新しい治療法が 肺癌と前立腺癌の 治療にどのように役立つかを調べています
科学分野:
- 腫瘍学
- 癌 生物学
- 分子病理学
背景:
- 系統の可塑性 つまり組織学的変容は 腫瘍細胞が標的治療から 逃れるための 重要な癌の進行メカニズムです
- この適応プロセスは,幹と表遺伝的変化によって駆動され,進行した,治療に抵抗するがんの治療戦略を複雑にします.
研究 の 目的:
- 組織学的変容を検出する際に組織および液体生検の診断的有用性を検討する.
- 治療に伴う新興の治療戦略と臨床的課題を調査する.
- 血統の可塑性に対する臨床的翻訳と薬物開発の枠組みを提供すること.
主な方法:
- 血統の可塑性の診断と管理に関する現在の証拠のレビュー
- 非小細胞肺がんと前立腺がんのモデルを検査する.
- 新しい分子標的と治療戦略の議論
主要な成果:
- バイオプシーは組織学的変異を検出し,サブタイプ特有の治療の調整に役立ちます.
- 新興の治療法では 治療に起因する血統の可塑性を 管理することが期待されています
- 先進がんの治療結果を改善するために 血統の可塑性を理解することが重要です
結論:
- 血統の可塑性は 重要な課題を提起しますが 新しい治療介入の機会も提供しています
- 組織および液体生検は組織学的変異の診断と管理に不可欠なツールです.
- 血統の可塑性に対する治療戦略を最適化するために,さらなる研究と臨床翻訳が必要である.
さらに関連する動画
09:44In Vitro Evaluation of Oncogenic Transformation in Human Mammary Epithelial Cells
Published on: September 24, 2020
4.7K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.1K
関連する概念動画
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
02:43Mouse Models of Cancer Study
5.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.7K
02:30Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K